Ad hoc Notice

The German Securities Trading Act (Sect 15 WpHG) obligates the party issuing publicly listed bonds to immediately publish and provide notice of solid information regarding circumstances not publicly known, which affect the issuing party directly and which are capable of significantly influencing the market price of the shares should they become public knowledge (referred to as ad hoc notices). This obligation to immediately make public information relevant to the stock price is intended to prevent an insider from exploiting advance knowledge to his/her advantage in stock trades.

In the following you will find the ad hoc notices made public by Vita 34.

08/08/2017

Vita 34 adjusts revenues and earnings targets for 2017

Vita 34 AG / Key word(s): Change in Forecast 08-Aug-2017 / 11:04 CET/CEST Disclosure of an inside information acc. to Article ... read more...


07/10/2017

Vita 34 AG resolves to implement rights issue against cash contributions by using its Authorized Capital

Vita 34 AG / Key word(s): Capital Increase 10-Jul-2017 / 19:21 CET/CEST Disclosure of an inside information acc. to Article ... read more...


06/13/2017

Vita 34 AG decides on a capital increase of around 10%

Vita 34 AG / Key word(s): Capital Increase 13-Jun-2017 / 18:31 CET/CEST Disclosure of an inside information acc. to Article ... read more...


06/12/2017

Vita 34 AG updates on planned capital increase and changes in the management

Vita 34 AG / Key word(s): Corporate Action/Change of Personnel 12-Jun-2017 / 17:43 CET/CEST Disclosure of an inside information ... read more...


04/20/2017

Vita 34 AG: Vita 34 concludes purchase agreement for the entire acquisition of its competitor Seracell Pharma AG

Vita 34 AG / Key word(s): Investment 20-Apr-2017 / 19:37 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, ... read more...


03/21/2016

Vita 34 AG increases Earnings per Share by 81 percent to EUR 0.67 and attains an EBITDA Margin of 27.5 percent

Vita 34 AG increases Earnings per Share by 81 percent to EUR 0.67 and attains an EBITDA Margin of 27.5 percent Leipzig, March ... read more...


09/08/2015

Vita 34 takes over Danish StemCare Group

Vita 34 takes over Danish StemCare Group Leipzig, September 8, 2015 - Vita 34 AG (WKN A0BL84) is taking over the business of ... read more...


07/22/2015

Vita 34 AG increases period result and EBITDA above average

Vita 34 AG increases period result and EBITDA above average - Period result increased threefold as of June 30, 2015 compared ... read more...


07/01/2015

Vita 34 AG: Vita 34 AG acquired 30 percent of company shares of the cooperation partner Bio Save (Serbia)

Vita 34 AG acquired 30 percent of company shares of the cooperation partner Bio Save (Serbia) Leipzig, July 1, 2015 - Vita 34 ... read more...


03/19/2015

Vita 34 AG: Management Board and Supervisory Board Pass Proposal for First Dividend Payment

Vita 34 AG: Management Board and Supervisory Board Pass Proposal for First Dividend Payment Leipzig, March 19, 2015 - The earnings ... read more...


to top